Alloplex Biotherapeutics develops a cellular therapeutic platform for treating cancer.
Description
Alloplex Biotherapeutics operates as a privately-owned Boston-based cellular therapeutics company. It has developed a non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Boston, Massachusetts, United States, North America